First Header Logo Second Header Logo

Connection

Elsayed Soliman to Hypertension

Back to Details
This is a "connection" page, showing publications Elsayed Soliman has written about Hypertension.
Elsayed Soliman
Connection Strength
8.869
Hypertension
  1. Ahmad MI, Kazibwe R, Soliman MZ, Singh S, Chen LY, Soliman EZ. Joint Association of Albuminuria and Left Ventricular Hypertrophy With Incident Heart Failure in Adults at High Risk With Hypertension: A Systolic Blood Pressure Intervention Trial Substudy. Am J Cardiol. 2023 Dec 01; 208:75-82.
    View in: PubMed
    Score: 0.549
  2. Garg PK, Wilson N, Yuan Y, Howard VJ, Judd S, Howard G, Soliman EZ. Association of hypertension severity and control with risk of incident atrial fibrillation: The REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Clin Cardiol. 2023 Nov; 46(11):1418-1425.
    View in: PubMed
    Score: 0.544
  3. Soliman EZ, Mills KT. Exploring the Relationship Between Intensive Blood Pressure Lowering, Left Ventricular Hypertrophy, and Cardiovascular Outcomes. Hypertension. 2023 Sep; 80(9):1843-1844.
    View in: PubMed
    Score: 0.543
  4. Imtiaz Ahmad M, Mendys PM, Kelly SP, Chen LY, Soliman EZ. Relationship Between High Blood Pressure, Atrial Cardiopathy, and Mortality in the General Population. Am J Hypertens. 2023 Jan 01; 36(1):33-41.
    View in: PubMed
    Score: 0.520
  5. Kamel H, Rahman AF, O'Neal WT, Lewis CE, Soliman EZ. Effect of intensive blood pressure lowering on left atrial remodeling in the SPRINT. Hypertens Res. 2021 10; 44(10):1326-1331.
    View in: PubMed
    Score: 0.472
  6. Soliman EZ, Rahman AF, Zhang ZM, Rodriguez CJ, Chang TI, Bates JT, Ghazi L, Blackshear JL, Chonchol M, Fine LJ, Ambrosius WT, Lewis CE. Effect of Intensive Blood Pressure Lowering on the Risk of Atrial Fibrillation. Hypertension. 2020 06; 75(6):1491-1496.
    View in: PubMed
    Score: 0.433
  7. Soliman EZ, Howard G, Judd S, Bhave PD, Howard VJ, Herrington DM. Factors Modifying the Risk of Atrial Fibrillation Associated With Atrial Premature Complexes in Patients With Hypertension. Am J Cardiol. 2020 05 01; 125(9):1324-1331.
    View in: PubMed
    Score: 0.426
  8. Ahmad MI, Mujtaba M, Anees MA, Li Y, Soliman EZ. Interrelation Between Electrocardiographic Left Atrial Abnormality, Left Ventricular Hypertrophy, and Mortality in Participants With Hypertension. Am J Cardiol. 2019 09 15; 124(6):886-891.
    View in: PubMed
    Score: 0.407
  9. Cao X, Broughton ST, Waits GS, Nguyen T, Li Y, Soliman EZ. Interrelations Between Hypertension and Electrocardiographic Left Ventricular Hypertrophy and Their Associations With Cardiovascular Mortality. Am J Cardiol. 2019 01 15; 123(2):274-283.
    View in: PubMed
    Score: 0.389
  10. Soliman EZ, Ambrosius WT, Lewis CE. Response by Soliman et al to Letters Regarding Article, "Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)". Circulation. 2018 03 20; 137(12):1300-1301.
    View in: PubMed
    Score: 0.373
  11. Waits GS, O'Neal WT, Sandesara PB, Li Y, Shah AJ, Soliman EZ. Association between low diastolic blood pressure and subclinical myocardial injury. Clin Res Cardiol. 2018 Apr; 107(4):312-318.
    View in: PubMed
    Score: 0.365
  12. Soliman EZ, Prineas RJ. Antihypertensive Therapies and Left Ventricular Hypertrophy. Curr Hypertens Rep. 2017 Sep 19; 19(10):79.
    View in: PubMed
    Score: 0.361
  13. Soliman EZ, Ambrosius WT, Cushman WC, Zhang ZM, Bates JT, Neyra JA, Carson TY, Tamariz L, Ghazi L, Cho ME, Shapiro BP, He J, Fine LJ, Lewis CE. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial). Circulation. 2017 Aug 01; 136(5):440-450.
    View in: PubMed
    Score: 0.352
  14. Chen LY, Bigger JT, Hickey KT, Chen H, Lopez-Jimenez C, Banerji MA, Evans G, Fleg JL, Papademetriou V, Thomas A, Woo V, Seaquist ER, Soliman EZ. Effect of Intensive Blood Pressure Lowering on Incident Atrial Fibrillation and P-Wave Indices in the ACCORD Blood Pressure Trial. Am J Hypertens. 2016 11 01; 29(11):1276-1282.
    View in: PubMed
    Score: 0.339
  15. Frimodt-Møller EK, Vittinghoff E, Kaur G, Biering-Sørensen T, Soliman EZ, Marcus GM. Association Between Intensive vs Standard Blood Pressure Control and Incident Left Ventricular Conduction Disease: A Post Hoc Analysis of the SPRINT Randomized Clinical Trial. JAMA Cardiol. 2023 Jun 01; 8(6):612-616.
    View in: PubMed
    Score: 0.134
  16. Ascher SB, de Lemos JA, Lee M, Wu E, Soliman EZ, Neeland IJ, Kitzman DW, Ballantyne CM, Nambi V, Killeen AA, Ix JH, Shlipak MG, Berry JD. Intensive Blood Pressure Lowering in Patients With Malignant Left Ventricular Hypertrophy. J Am Coll Cardiol. 2022 Oct 18; 80(16):1516-1525.
    View in: PubMed
    Score: 0.128
  17. Skipina TM, Patel N, Upadhya B, Soliman EZ. Relation of Cannabis Use to Elevated Atherosclerotic Cardiovascular Disease Risk Score. Am J Cardiol. 2022 02 15; 165:46-50.
    View in: PubMed
    Score: 0.121
  18. Skipina TM, Soliman EZ, Upadhya B. Association between secondhand smoke exposure and hypertension: nearly as large as smoking. J Hypertens. 2020 10; 38(10):1899-1908.
    View in: PubMed
    Score: 0.111
  19. Afify H, Lee HL, Soliman EZ, Singleton MJ. Prognostic significance of body mass index-adjusted criteria for left ventricular hypertrophy. J Clin Hypertens (Greenwich). 2020 08; 22(8):1476-1483.
    View in: PubMed
    Score: 0.110
  20. Rattani A, Claxton JS, Ali MK, Chen LY, Soliman EZ, Alvaro A. Association and impact of hypertension defined using the 2017 AHA/ACC guidelines on the risk of atrial fibrillation in The Atherosclerosis Risk in Communities study. BMC Cardiovasc Disord. 2019 11 26; 19(1):262.
    View in: PubMed
    Score: 0.105
  21. Kim JS, Azarbarzin A, Wang R, Djonlagic IE, Punjabi NM, Zee PC, Koo BB, Soliman EZ, Younes M, Redline S. Association of novel measures of sleep disturbances with blood pressure: the Multi-Ethnic Study of Atherosclerosis. Thorax. 2020 01; 75(1):57-63.
    View in: PubMed
    Score: 0.103
  22. Brooks JE, Soliman EZ, Upadhya B. Is Left Ventricular Hypertrophy a Valid Therapeutic Target? Curr Hypertens Rep. 2019 05 20; 21(6):47.
    View in: PubMed
    Score: 0.101
  23. Dewland TA, Soliman EZ, Yamal JM, Davis BR, Alonso A, Albert CM, Simpson LM, Haywood LJ, Marcus GM. Pharmacologic Prevention of Incident Atrial Fibrillation: Long-Term Results From the ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial). Circ Arrhythm Electrophysiol. 2017 Dec; 10(12).
    View in: PubMed
    Score: 0.091
  24. Weng LC, Lunetta KL, Müller-Nurasyid M, Smith AV, Thériault S, Weeke PE, Barnard J, Bis JC, Lyytikäinen LP, Kleber ME, Martinsson A, Lin HJ, Rienstra M, Trompet S, Krijthe BP, Dörr M, Klarin D, Chasman DI, Sinner MF, Waldenberger M, Launer LJ, Harris TB, Soliman EZ, Alonso A, Paré G, Teixeira PL, Denny JC, Shoemaker MB, Van Wagoner DR, Smith JD, Psaty BM, Sotoodehnia N, Taylor KD, Kähönen M, Nikus K, Delgado GE, Melander O, Engström G, Yao J, Guo X, Christophersen IE, Ellinor PT, Geelhoed B, Verweij N, Macfarlane P, Ford I, Heeringa J, Franco OH, Uitterlinden AG, Völker U, Teumer A, Rose LM, Kääb S, Gudnason V, Arking DE, Conen D, Roden DM, Chung MK, Heckbert SR, Benjamin EJ, Lehtimäki T, März W, Smith JG, Rotter JI, van der Harst P, Jukema JW, Stricker BH, Felix SB, Albert CM, Lubitz SA. Genetic Interactions with Age, Sex, Body Mass Index, and Hypertension in Relation to Atrial Fibrillation: The AFGen Consortium. Sci Rep. 2017 09 12; 7(1):11303.
    View in: PubMed
    Score: 0.090
  25. Cho ME, Craven TE, Cheung AK, Glasser SP, Rahman M, Soliman EZ, Stafford RS, Johnson KC, Bates JT, Burgner A, Taylor AA, Tamariz L, Tang R, Beddhu S. The association between insulin resistance and atrial fibrillation: A cross-sectional analysis from SPRINT (Systolic Blood Pressure Intervention Trial). J Clin Hypertens (Greenwich). 2017 Nov; 19(11):1152-1161.
    View in: PubMed
    Score: 0.090
  26. Bang CN, Soliman EZ, Simpson LM, Davis BR, Devereux RB, Okin PM. Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study. Am J Hypertens. 2017 Sep 01; 30(9):914-922.
    View in: PubMed
    Score: 0.090
  27. Tereshchenko LG, Soliman EZ, Davis BR, Oparil S. Risk stratification of sudden cardiac death in hypertension. J Electrocardiol. 2017 Nov - Dec; 50(6):798-801.
    View in: PubMed
    Score: 0.090
  28. Haywood LJ, Davis BR, Piller LB, Simpson LM, Ghosh A, Einhorn PT, Ford CE, Probstfield JL, Soliman EZ, Wright JT. Risk Factors Influencing Outcomes of Atrial Fibrillation in ALLHAT. J Natl Med Assoc. 2018 Aug; 110(4):343-351.
    View in: PubMed
    Score: 0.089
  29. Haywood LJ, Davis BR, Piller LB, Cushman WC, Cutler JA, Ford CE, Simpson LM, Ghosh A, Soliman EZ, Wright JT. Influence of Prevalent and Incident Atrial Fibrillation on Post-Trial Major Events in ALLHAT. J Natl Med Assoc. 2017 Autumn; 109(3):172-181.
    View in: PubMed
    Score: 0.087
  30. Ernst ME, Davis BR, Soliman EZ, Prineas RJ, Okin PM, Ghosh A, Cushman WC, Einhorn PT, Oparil S, Grimm RH. Electrocardiographic measures of left ventricular hypertrophy in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. J Am Soc Hypertens. 2016 12; 10(12):930-938.e9.
    View in: PubMed
    Score: 0.085
  31. Howard G, Safford MM, Moy CS, Howard VJ, Kleindorfer DO, Unverzagt FW, Soliman EZ, Flaherty ML, McClure LA, Lackland DT, Wadley VG, Pulley L, Cushman M. Racial Differences in the Incidence of Cardiovascular Risk Factors in Older Black and White Adults. J Am Geriatr Soc. 2017 01; 65(1):83-90.
    View in: PubMed
    Score: 0.084
  32. Bhatt H, Gamboa CM, Safford MM, Soliman EZ, Glasser SP. Prevalence of electrocardiographic abnormalities based on hypertension severity and blood pressure levels: the Reasons for Geographic and Racial Differences in Stroke study. J Am Soc Hypertens. 2016 09; 10(9):702-713.e4.
    View in: PubMed
    Score: 0.083
  33. Ghazi L, Safford MM, Khodneva Y, O'Neal WT, Soliman EZ, Glasser SP. Gender, race, age, and regional differences in the association of pulse pressure with atrial fibrillation: the Reasons for Geographic and Racial Differences in Stroke study. J Am Soc Hypertens. 2016 08; 10(8):625-632.e1.
    View in: PubMed
    Score: 0.082
  34. Soliman EZ, Backlund JY, Bebu I, Li Y, Zhang ZM, Cleary PA, Lachin JM. Progression of Electrocardiographic Abnormalities in Type 1 Diabetes During 16 Years of Follow-up: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study. J Am Heart Assoc. 2016 Mar 14; 5(3):e002882.
    View in: PubMed
    Score: 0.081
  35. Soliman EZ, Byington RP, Bigger JT, Evans G, Okin PM, Goff DC, Chen H. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial. Hypertension. 2015 Dec; 66(6):1123-9.
    View in: PubMed
    Score: 0.079
  36. Soliman EZ, Lopez F, O'Neal WT, Chen LY, Bengtson L, Zhang ZM, Loehr L, Cushman M, Alonso A. Atrial Fibrillation and Risk of ST-Segment-Elevation Versus Non-ST-Segment-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2015 May 26; 131(21):1843-50.
    View in: PubMed
    Score: 0.076
  37. Zulqarnain MA, Qureshi WT, O'Neal WT, Shah AJ, Soliman EZ. Risk of Mortality Associated With QT and JT Intervals at Different Levels of QRS Duration (from the Third National Health and Nutrition Examination Survey). Am J Cardiol. 2015 Jul 01; 116(1):74-8.
    View in: PubMed
    Score: 0.076
  38. O'Neal WT, Soliman EZ, Qureshi W, Alonso A, Heckbert SR, Herrington D. Sustained pre-hypertensive blood pressure and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis. J Am Soc Hypertens. 2015 Mar; 9(3):191-6.
    View in: PubMed
    Score: 0.075
  39. O'Neal WT, Efird JT, Nazarian S, Alonso A, Heckbert SR, Soliman EZ. Mitral annular calcification and incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis. Europace. 2015 Mar; 17(3):358-63.
    View in: PubMed
    Score: 0.074
  40. Soliman EZ, Safford MM, Muntner P, Khodneva Y, Dawood FZ, Zakai NA, Thacker EL, Judd S, Howard VJ, Howard G, Herrington DM, Cushman M. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med. 2014 Jan; 174(1):107-14.
    View in: PubMed
    Score: 0.070
  41. Alonso A, Soliman EZ, Chen LY, Bluemke DA, Heckbert SR. Association of blood pressure and aortic distensibility with P wave indices and PR interval: the multi-ethnic study of atherosclerosis (MESA). J Electrocardiol. 2013 Jul-Aug; 46(4):359.e1-6.
    View in: PubMed
    Score: 0.066
  42. Ernst ME, Neaton JD, Grimm RH, Collins G, Thomas W, Soliman EZ, Prineas RJ. Long-term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the multiple risk factor intervention trial. Hypertension. 2011 Dec; 58(6):1001-7.
    View in: PubMed
    Score: 0.060
  43. Soliman EZ, Prineas RJ, Case LD, Russell G, Rosamond W, Rea T, Sotoodehnia N, Post WS, Siscovick D, Psaty BM, Burke GL. Electrocardiographic and clinical predictors separating atherosclerotic sudden cardiac death from incident coronary heart disease. Heart. 2011 Oct; 97(19):1597-601.
    View in: PubMed
    Score: 0.059
  44. Soliman EZ, Juma H. Cardiac disease patterns in northern Malawi: epidemiologic transition perspective. J Epidemiol. 2008; 18(5):204-8.
    View in: PubMed
    Score: 0.048
  45. Costa MD, Redline S, Soliman EZ, Goldberger AL, Heckbert SR. Fragmented sinoatrial dynamics in the prediction of atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis. Am J Physiol Heart Circ Physiol. 2021 01 01; 320(1):H256-H271.
    View in: PubMed
    Score: 0.028
  46. Howard VJ, Madsen TE, Kleindorfer DO, Judd SE, Rhodes JD, Soliman EZ, Kissela BM, Safford MM, Moy CS, McClure LA, Howard G, Cushman M. Sex and Race Differences in the Association of Incident Ischemic Stroke With Risk Factors. JAMA Neurol. 2019 02 01; 76(2):179-186.
    View in: PubMed
    Score: 0.025
  47. Rodriguez CJ, Soliman EZ, Alonso A, Swett K, Okin PM, Goff DC, Heckbert SR. Atrial fibrillation incidence and risk factors in relation to race-ethnicity and the population attributable fraction of atrial fibrillation risk factors: the Multi-Ethnic Study of Atherosclerosis. Ann Epidemiol. 2015 Feb; 25(2):71-6, 76.e1.
    View in: PubMed
    Score: 0.019
  48. Perez MV, Wang PJ, Larson JC, Soliman EZ, Limacher M, Rodriguez B, Klein L, Manson JE, Martin LW, Prineas R, Connelly S, Hlatky M, Wassertheil-Smoller S, Stefanick ML. Risk factors for atrial fibrillation and their population burden in postmenopausal women: the Women's Health Initiative Observational Study. Heart. 2013 Aug; 99(16):1173-8.
    View in: PubMed
    Score: 0.017
  49. Alonso A, Krijthe BP, Aspelund T, Stepas KA, Pencina MJ, Moser CB, Sinner MF, Sotoodehnia N, Fontes JD, Janssens AC, Kronmal RA, Magnani JW, Witteman JC, Chamberlain AM, Lubitz SA, Schnabel RB, Agarwal SK, McManus DD, Ellinor PT, Larson MG, Burke GL, Launer LJ, Hofman A, Levy D, Gottdiener JS, Kääb S, Couper D, Harris TB, Soliman EZ, Stricker BH, Gudnason V, Heckbert SR, Benjamin EJ. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc. 2013 Mar 18; 2(2):e000102.
    View in: PubMed
    Score: 0.016
  50. Prineas RJ, Le A, Soliman EZ, Zhang ZM, Howard VJ, Ostchega Y, Howard G. United States national prevalence of electrocardiographic abnormalities in black and white middle-age (45- to 64-Year) and older (=65-Year) adults (from the Reasons for Geographic and Racial Differences in Stroke Study). Am J Cardiol. 2012 Apr 15; 109(8):1223-8.
    View in: PubMed
    Score: 0.015
  51. Tanner RM, Baber U, Carson AP, Voeks J, Brown TM, Soliman EZ, Howard VJ, Muntner P. Association of the metabolic syndrome with atrial fibrillation among United States adults (from the REasons for Geographic and Racial Differences in Stroke [REGARDS] Study). Am J Cardiol. 2011 Jul 15; 108(2):227-32.
    View in: PubMed
    Score: 0.014
  52. Huxley RR, Lopez FL, Folsom AR, Agarwal SK, Loehr LR, Soliman EZ, Maclehose R, Konety S, Alonso A. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2011 Apr 12; 123(14):1501-8.
    View in: PubMed
    Score: 0.014
  53. Zhang ZM, Prineas RJ, Case D, Soliman EZ, Rautaharju PM. Comparison of the prognostic significance of the electrocardiographic QRS/T angles in predicting incident coronary heart disease and total mortality (from the atherosclerosis risk in communities study). Am J Cardiol. 2007 Sep 01; 100(5):844-9.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.